According to the latest filing with the U.S. Securities and Exchange Commission (SEC), NEUROONE MEDICAL TECH has made explicit forecasts regarding its future performance.

老虎证券2026/02/17 13:18

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

The company expects its product revenue to achieve significant growth by 2026, reaching a minimum of $10.5 million. This projection reflects the company's confidence in its technological products and market prospects. As the medical technology industry continues to develop, NEUROONE MEDICAL TECH is actively positioning itself to occupy a more important place in the field of neuro-medical technology. The disclosure in the SEC filing provides investors with key financial guidance, helping the market more accurately assess the company's growth potential and investment value.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to the latest filing with the U.S. Securities and Exchange Commission (SEC), NEUROONE MEDICAL TECH has made explicit forecasts regarding its future performance.

You may also like

Crypto prices